President Ferdinand R. Marcos Jr. wants quality health services to be accessible to all Filipinos, particularly those living ...

MANILA, Philippines — The Department of Health (DOH) said on Friday that it is “actively verifying” information about an alleged “international health concern” circulating online.

According to Dr. Albert Domingo, the OIC assistant secretary and spokesperson of the DOH, said the Philippines is an active participant in the network of WHO Member States that follow the ...

MANILA, Jan. 2 (Xinhua) -- The Philippines' Department of Health (DOH) on Thursday said it tallied 188 additional firecracker-related injuries nationwide during Christmas and New Year revelries, ...

December 23, 2024, the U.S. Food and Drug Administration approved the first generic referencing Victoza (liraglutide injection) 18 milligram/3 milliliter, a glucagon-like peptide-1 (GLP-1) receptor ...

MANILA, Philippines — The Department of Health (DOH) reported an increase in road accidents, with a total of 418 incidents recorded since December 22. In the past 24 hours on Sunday, December 29 ...

THURSDAY, Dec. 26, 2024 (HealthDay News) -- The U.S. Food and Drug Administration has approved the first generic referencing Victoza (liraglutide; Hikma Pharmaceuticals), a glucagon-like peptide-1 ...

Hopefully, the approval will help prevent shortages triggered by demand for injectable weight loss drugs such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) There is still no ...

MANILA, Philippines — The number of recorded firework-related injuries rose to 43 on Christmas Day, said the Department of Health (DOH). According to the DOH in a statement, the injuries were ...

The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide for people with type 2 diabetes, opening the door for lower-priced ...

In a move that could eventually make weight loss drugs cheaper and easier to access, the Food and Drug Administration Monday approved a second generic in the category of medications known as GLP-1s.